These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8993407)

  • 1. Region-specific regulation of neurogenesis by VIP and PACAP: direct and indirect modes of action.
    DiCicco-Bloom E
    Ann N Y Acad Sci; 1996 Dec; 805():244-56; discussion 256-8. PubMed ID: 8993407
    [No Abstract]   [Full Text] [Related]  

  • 2. Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms.
    Braas KM; May V
    Ann N Y Acad Sci; 1996 Dec; 805():204-16; discussion 217-8. PubMed ID: 8993404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple receptors for PACAP and VIP.
    Harmar T; Lutz E
    Trends Pharmacol Sci; 1994 Apr; 15(4):97-9. PubMed ID: 7912462
    [No Abstract]   [Full Text] [Related]  

  • 4. [The neuropeptide PACAP: its presence, its mode of action and its receptors].
    Christophe J
    Bull Mem Acad R Med Belg; 1993; 148(3-4):188-93. PubMed ID: 7906174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M; Ganea D
    J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide stimulates neuropeptide Y gene expression and causes neurite extension in PC12 cells through independent mechanisms.
    Colbert RA; Balbi D; Johnson A; Bailey JA; Allen JM
    J Neurosci; 1994 Nov; 14(11 Pt 2):7141-7. PubMed ID: 7965104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.
    Maduna T; Lelievre V
    J Neurosci Res; 2016 Dec; 94(12):1472-1487. PubMed ID: 27717098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of VIP and nitric oxide in the regulation of neuromuscular function in the gut.
    Murthy KS; Grider JR; Jin JG; Makhlouf GM
    Ann N Y Acad Sci; 1996 Dec; 805():355-62; discussion 362-3. PubMed ID: 8993416
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurotrophism, mitogenesis, and nerve regeneration as models for neuropeptide mediation. Introduction to Part VI.
    Brenneman DE
    Ann N Y Acad Sci; 1994 Oct; 739():226-7. PubMed ID: 7832476
    [No Abstract]   [Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
    Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
    Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.
    Delgado M; Sun W; Leceta J; Ganea D
    J Immunol; 1999 Oct; 163(8):4213-23. PubMed ID: 10510358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
    Delgado M; Ganea D
    J Immunol; 2000 Feb; 164(3):1200-10. PubMed ID: 10640731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase activating polypeptide stimulates rat Leydig cell steroidogenesis through a novel transduction pathway.
    Rossato M; Nogara A; Gottardello F; Bordon P; Foresta C
    Endocrinology; 1997 Aug; 138(8):3228-35. PubMed ID: 9231772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive mechanisms among pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide, and parathyroid hormone receptors in guinea pig cecal circular smooth muscle cells.
    Motomura Y; Chijiiwa Y; Iwakiri Y; Ochiai T; Nawata H
    Endocrinology; 1998 Jun; 139(6):2869-78. PubMed ID: 9607796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptide inhibits the cyclooxygenase pathway of rat cerebral microvessels.
    Kis B; Gáspár T; Mezei Z; Gecse A; Telegdy G
    Acta Physiol Scand; 1999 Sep; 167(1):43-7. PubMed ID: 10519976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.